Brooks Laboratories Ltd
NSE:BROOKS

Watchlist Manager
Brooks Laboratories Ltd Logo
Brooks Laboratories Ltd
NSE:BROOKS
Watchlist
Price: 65.29 INR 4.98% Market Closed
Market Cap: ₹1.9B

Wall St Price Targets

BROOKS Price Targets Summary
Brooks Laboratories Ltd

There are no price targets for BROOKS.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Brooks Laboratories Ltd Competitors:
Price Targets
VLA
Valneva SE
131% Upside
CNTX
Context Therapeutics Inc
119% Upside
TPST
Tempest Therapeutics Inc
674% Upside
TMO
Thermo Fisher Scientific Inc
29% Upside

Revenue
Forecast

3% / Year
Past Growth
1% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
3% / Year
Past Growth
1% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 10 years is 1%.

Operating Income
Forecast

-8% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-8% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been -8%. The projected CAGR for the next 10 years is 11%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BROOKS's stock price target?
Not Available

BROOKS does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Brooks Laboratories Ltd?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 10 years is 1%.

What is the Operating Income forecast for Brooks Laboratories Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been -8%. The projected CAGR for the next 10 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett